Status:
RECRUITING
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Lead Sponsor:
Alison Stopeck
Conditions:
Breast Cancer
Locally Advanced Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to compare a special type of mammogram that uses a contrast agent called contrast-enhanced digital mammography with contrast-enhanced digital breast tomosynthesis (CEDM+CE...
Eligibility Criteria
Inclusion
- Diagnosis with either type of invasive locally advanced breast cancer regardless of hormone receptor or Her2 status
- Plan to receive at least 4 cycles of neoadjuvant chemotherapy ahead of definitive surgery
Exclusion
- Pregnancy
- Allergy/sensitivity to contrast agent
- Decreased kidney function
- Diabetes
Key Trial Info
Start Date :
March 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06220214
Start Date
March 6 2024
End Date
August 31 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stony Brook Breast Center
Stony Brook, New York, United States, 11794